Buck Launches Bitcoin-Pegged Savings Coin "BUCK," with Yield from Strategy-Related Assets
BlockBeats News, January 6th, according to CoinDesk, Buck Labs has launched the cryptocurrency token BUCK, positioned as a "Savings Coin" for non-U.S. users, focusing on providing passive income for USD-denominated crypto assets, rather than traditional stablecoins.
BUCK has an initial price of 1 USD, with no strict USD peg, allowing the price to fluctuate with the market. Its revenue is indirectly derived from assets related to Strategy (MSTR): the Buck Foundation holds STRC perpetual preferred shares pegged to Bitcoin, which pay periodic returns to the treasury, used to distribute rewards to BUCK holders, with a current annualized target of around 7%, compounded by the minute.
Buck Labs emphasizes that Michael Saylor and Strategy are not involved, sponsored, or endorsed the project. BUCK adopts a governance token structure, allowing holders to participate in revenue distribution and other governance votes, with the company stating that it is not issuing securities. BUCK aims to complement stablecoins rather than replace them, targeting users looking for relatively predictable crypto income but unwilling to trade frequently.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
S&P Dow Jones Partners With Kalshi as Prediction Markets Enter Mainstream
130% Near Protocol (NEAR) Surge in Spot Inflows Secures $1.3 Million

Unable to recover 817 bitcoin, Datavault AI (DVLT.US) stock price slashed in half
Datavault AI has confirmed that it has been unable to withdraw Bitcoin from Biconomy since June, resulting in a failed asset transfer and forcing the company to restate its financial reports. As a result, its share price plummeted by 49.55% in a single day, and its book assets are expected to shrink significantly.

Regenerative medicine device company RegenLab USA (RGNA.US) sets IPO price at $6–$8 per share, aiming to raise $18 million
RegenLab USA announced its IPO terms on Tuesday.
